Magazine article from our research archive:

First generic of Zofran.(Updates)(SICOR Pharmaceuticals Inc.; Kali Laboratories Inc.)(Brief article)

The FDA has approved the first generic versions of Zofran (ondansetron) injection, injection premixed, tablets, orally disintegrating tablets, and oral solution.

Ondansetron is indicated to prevent nausea and vomiting associated with surgery, radiotherapy, and cancer chemotherapy. Ondansetron Injection and Injection Premixed were approved in November 2006. Ondansetron Tablets, Orally Disintegrating Tablets, and Oral Solution were approved in December 2006.

The approvals are an important step in the agency's effort to increase the availability of lower-cost generic medications. In 2005, Zofran was the 20th ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!